Study on the effectiveness of stenting for obstructive colorectal cancer at Niigata City Hospital

Comparison of the oncological outcomes of stenting as a bridge to surgery and surgery alone in obstructive colorectal cancer; a retrospective study - Comparison stenting as a bridge to surgery and surgery alone in obstructive colorectal cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000040771

Enrollment

100

Registered

2020-06-15

Start date

2020-04-20

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obstructive colorectal cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients who underwent curative resection for obstructive colorectal cancer at Niigata City General Hospital were divided into the bridge to surgery with stenting group (treated from April 2012, when stenting for malignant bowel obstruction was covered by insurance in Japan, to 2019) and the surgery alone group (treated from 2008 to 2019). The surgery alone group included patients who did not undergo decompression and patients who underwent non-surgical bowel decompression at the oral side of obstructive colorectal cancer and had a nasal ileus tube or nasogastric tube placed before curative resection. In this study, obstructive colorectal cancer was diagnosed by computed tomography (CT) and colonoscopy in which urgent decompression was deemed necessary.

Exclusion criteria

Exclusion criteria: The patients who underwent preoperative bowel decompression procedures by trans-anal tube or stoma creation at the oral side of the cancer were excluded.

Design outcomes

Primary

Measure	Time frame
Postoperative recurrence rate through 8 years after introduction of colorectal stent at Niigata City General Hospital.	—

Secondary

Measure	Time frame
the short-term surgical outcome, survival rate, recurrence sites.	—

Countries

Japan

Contacts

Public ContactHiroaki Uehara

Niigata City General Hospital Department of Digestive Surgery

hiroaki.u@hotmail.co.jp+81-25-281-5151

Outcome results